
|Articles|August 1, 2006
- Pharmaceutical Executive-08-01-2006
- Volume 0
- Issue 0
Getting Better
Is the golden age of drug development over? Fat chance. Decade-by-decade comparisons show how new medicines improve on old ones. And that's innovation.
Advertisement
Articles in this issue
almost 20 years ago
Time Machinealmost 20 years ago
States Curb Marketingalmost 20 years ago
From the Editor: Take Your Seatalmost 20 years ago
Viewpoint: In Your Wordsalmost 20 years ago
Quiz Answersalmost 20 years ago
Introduction: Pharm Exec at 25almost 20 years ago
How Far We've ComeAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond JAK Inhibitors: Biologics Signal a New Era in Alopecia Areata
2
Pharma M&A Roundup: Incyte to Acquire Vega Therapeutics, Galmed Pharmaceuticals to Acquire Colospan, Johnson & Johnson Acquires Firefly Bio
3
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
4
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
5



